McCorkle, J.R.; Ahn, R.; Cao, C.D.; Hill, K.S.; Dietrich, C.S.; Kolesar, J.M.
Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer. Cancers 2024, 16, 1321.
https://doi.org/10.3390/cancers16071321
AMA Style
McCorkle JR, Ahn R, Cao CD, Hill KS, Dietrich CS, Kolesar JM.
Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer. Cancers. 2024; 16(7):1321.
https://doi.org/10.3390/cancers16071321
Chicago/Turabian Style
McCorkle, J. Robert, Rebecca Ahn, Connie D. Cao, Kristen S. Hill, Charles S. Dietrich, and Jill M. Kolesar.
2024. "Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer" Cancers 16, no. 7: 1321.
https://doi.org/10.3390/cancers16071321
APA Style
McCorkle, J. R., Ahn, R., Cao, C. D., Hill, K. S., Dietrich, C. S., & Kolesar, J. M.
(2024). Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer. Cancers, 16(7), 1321.
https://doi.org/10.3390/cancers16071321